Dealing with a start up Bio Tech company working on Pancreatic Cancer with GP 2250 and other cancer applications|Greg Bosch , CEO OF PANAVANCE THERAPEUTICS INC 00:10:00
Greg Bosch brings over 30 years in healthcare to Panavance with leadership of commercial, operations, and R&D teams in the US and Europe. His general management experience in the life science industry spans the pharmaceutical, biologics and medical device segments including building a biosurgery business to $220M in 5 years